Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04968561
Other study ID # 2020 Becaud Nora
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 2, 2020
Est. completion date October 2021

Study information

Verified date July 2021
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone 334.73.754.963
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The gold standard surgical treatment for benign nasosinus pathologies is endoscopic surgery. This surgery has experienced considerable growth over the last 30 years. Nevertheless, these techniques can potentially lead to serious complications, with risks of damaging adjacent structures (orbit, optic nerve, meninge or internal carotid artery). Therefore, improving the safety of these procedures is a fundamental objective. Recently, computer-assisted surgery, allowing endonasal navigation, has emerged. It appears to be an asset for the patient, limiting complications and morbidity, and for the surgeon, improving his comfort and reducing his mental workload. The major pitfall of the current technique is the loss of localisation reliability during the intervention due to the registration process and the presence of two screens (to locate the object on the endoscopic image and on the scan) We would like to propose solutions to these limitations using a device based on augmented reality and 3D reconstructions. It would guide the gesture in endonasal endoscopic surgery by displaying high-risk areas and surgical landmarks in a reliable and precise way.


Description:

The available literature offers numerous expert and consensus opinions supporting the usefulness and acceptance of endonasal navigation and encouraging development of optimised navigation systems Augmented reality (AR) allows the surgeon to visualise the preoperative imaging information in the form of a projection that is displayed on the endoscopic image screen. This application, used in other surgical fields, is promising. The EnCoV team of the Institut Pascal laboratory has notably developed an innovative functional AR system, in laparoscopy in gynaecological, digestive and urological surgery The feasibility in endonasal surgery has been confirmed in a cadaveric model and its clinical utility shown on various systems. However, the question of accuracy during calibration and during the surgery remains. We propose a surface registration system based on 3D reconstructions of patient's face and endoscopic images. It would match 3D reconstructions of the patient's images with 3D reconstructions of the CT scan or MRI images. Thus, this device would be able to provide a large number of reference points for precise mapping. Tissue recognition (texture, contours, etc.) processes would allow to display the right information in the right place. To date, there is no such AR endonasal navigation system. Thus, the technical evolutions developed in laparoscopy by the EnCoV team would be transposed the ENT field in order to optimise endonasal endoscopy. Outline of the study : Feasibility study, observational, transversal. Feasibility criterion: To evaluate the feasibility of a device based on AR to guide the gesture in endonasal endoscopic surgery by displaying invisible high-risk areas and surgical landmarks in a reliable and accurate way. 1. Development of a questionnaire for AFR and SJORL ENT surgeons in order to assess their needs and the interest of implementing such a navigation 2. Study of the feasibility of integrating, in the laboratory, CT scan images with facial and endonasal images filmed in the operating theatre, to form a qualitative clinical study. - Patients and data acquisition: - Data acquisition The images will be collected in the operating theatre of the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand. They will be obtained from videos of the face and endonasal anatomy filmed using the endoscope. All these images will be anonymised. - Duration of inclusion: 12 months (November 2020- October 2021) - Number of patients: Intermediate stages with analysis every 5 patients for the first 15 patients and then every 10 patients will be realised, adapting the recording methods and algorithms to the results. This will be a progressive process of adjustment and refinement. The methods for recording patient data in the operating theatre will evolve in order to optimise image processing. The annual recruitment capacity is 50 patients; a maximum number of 30 to 40 patients is expected. - Written consent: prospective collection of the patient's non-opposition - Duration of each patient's participation: 1 day - Data processing: This will be a collaborative work with the EnCoV team under the responsibility of Pr A. BARTOLI. The most relevant images will be extracted, corrected and then transformed into a 3D model in order to acquire depth data. The CT scan images will also be transformed into 3D format. These two 3D models (from the patient and from the imaging) will be merged using an algorithm, in order to allow surface registration. The data will first be stored on the EnCoV servers. 3. Validation of the navigation system by experimenting it on phantom models made from 3D printing and ex vivo animal models, to form a quantitative preclinical study. In endonasal endoscopy procedures the validity of the display of easily recognisable structures will be checked.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date October 2021
Est. primary completion date September 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients - Admitted in the ENT and Cervico-Facial Surgery department of the Gabriel Montpied University Hospital in Clermont-Ferrand. - From November 2020 to October 2021, - Requiring endoscopic sinus surgery - With good quality imaging (CT scan and/or MRI) Exclusion Criteria: - Patient under the age of 18

Study Design


Locations

Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (6)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Audition Conseil, Bourse Année-Recherche par l'Agence Régionale de Santé Auvergne Rhone Alpes pour Mme Luce COMPAGNONE pour l'année 2020-2021, CHU Clermont-Ferrand (Appel d'offre Interne), Collin medical, Institut Pascal (CNRS 6602/ Université Clermont Auvergne / SIGMA), équipe EnCoV

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Target registration error The feasibility of integrating medical imaging data with endoscopic images will be assessed by the accuracy of the registration obtained, called TRE (Target Registration Error). This is a standard evaluation methodology of a registration between modalities. day 1
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03436576 - Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye Phase 3
Completed NCT02386774 - Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa N/A
Completed NCT06428266 - Closed Dacryointubation vs Bicanalicular Intubation for Proximal Tear Duct Obstruction N/A
Completed NCT00706251 - Follow up of Nasolacrimal Intubation in Adults N/A
Completed NCT01826734 - Analysis of 86 Dacryoliths at the University Hospital Ostrava N/A
Completed NCT04240431 - Level of Lacrimal Passage Obstruction
Completed NCT03706443 - Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops N/A